Folsom Metal Products recalled 3,790 distraction pins on August 21, 2025. The recall affects all lots distributed from August 1, 2020, to July 30, 2025. The labeling lacks a validated shelf life, posing a high hazard risk.
Labeling includes shelf life that has not been validated.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Folsom Metal Products, Inc. or your healthcare provider for instructions. Notification method: Letter
The recalled product is the 12 mm Distraction Pin, REF: 301.912S1. It comes in packs of 10 and is distributed nationwide in states including California, Florida, and Texas.
The recall stems from labeling that includes an unvalidated shelf life. This could lead to the use of potentially ineffective or unsafe medical devices.
No specific incidents or injuries have been reported related to this recall. The risk level is classified as high due to the nature of medical devices.
Patients and healthcare providers must stop using the recalled distraction pins immediately. Follow the instructions provided by the manufacturer and contact Folsom Metal Products, Inc. for further assistance.
For more information, contact Folsom Metal Products, Inc. at their official website or through the provided FDA recall notification letter.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.